This inventor holds 1 USPTO granted patent. Top assignee: Bayer Healthcare LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jesper Mortensen Haaning: Innovator in Coagulation Therapy
Introduction
Jesper Mortensen Haaning is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of coagulation therapy through his innovative research and development.
Latest Patents
Haaning holds a patent for "Factor VII or VIIa polypeptide variants." This invention relates to novel polypeptide variants of factor VII (FVII) or factor VIIa (FVIIa) polypeptides. The variants comprise an amino acid substitution in positions 10 and 32, along with a sugar moiety covalently attached to an introduced in vivo N-glycosylation site located outside of the Gla domain. These polypeptide variants are particularly useful in therapy for treating various coagulation-related disorders, such as trauma. He has 1 patent to his name.
Career Highlights
Haaning is currently employed at Bayer Healthcare LLC, where he continues to advance his research in the field of coagulation. His work has the potential to significantly impact therapeutic approaches to coagulation disorders.
Collaborations
Haaning collaborates with Kim Vilbour Andersen, contributing to the innovative research environment at Bayer Healthcare LLC.
Conclusion
Jesper Mortensen Haaning is a dedicated inventor whose work in coagulation therapy exemplifies the importance of innovation in medical science. His contributions are paving the way for new treatment options for patients with coagulation-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile